ArticleTherapeutic advances in gastroenterology2025

Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn's disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study.

Guillaume Le Cosquer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.